The Decade-by-Decade Screen Map

A screening schedule is not a fixed list you keep forever; it is a moving target. The map adds tests as the risk curves bend with age — and, in the part most checklists skip, it starts subtracting them when the arithmetic reverses. This page is the map, decade by decade, with the reason behind every entry.

Why the Map Changes Every Ten Years

Two forces redraw the map with every decade. The first is incidence: the diseases screening targets become more common as you age, which is why tests appear in the schedule at the ages where catching disease early pays off. The second is life expectancy: the value of finding a slow-growing cancer depends on how much life is left to protect, so as competing causes of death accumulate, the benefit column of every test shrinks. Screening is arithmetic — the chance of finding treatable disease, minus the cost of false positives, anxiety, and overdiagnosis — and both sides of that equation move with age. The parent Screening & Prevention topic walks the trade in detail; this page shows where the trade lands, decade by decade.

The 40s — The Baseline Decade

The 40s are when the map takes shape, because this is the decade where the slow diseases first become findable and the schedule's two heaviest hitters both enter. Nothing here requires symptoms; the point is to catch drift before it has a voice.

• 🫀 Blood pressure, every checkup. The highest-value measurement in the room — silent, cheap, and directly actionable. The Blood Pressure topic owns the interpretation.
• 🧪 Lipids and HbA1c, from around 40. A baseline lipid panel plus a glucose or HbA1c check catches the metabolic diseases that out-kill every cancer on this map; the Lipid Panel topic and the insulin-resistance topic explain the numbers.
• 🎀 Mammography at 40, biennial. The USPSTF's 2024 statement moved the recommended start to 40. The 40-vs-45-vs-50 debate is real and unresolved — the next page in this series takes it apart.
• 🌸 Cervical screening continues. HPV testing every five years (or Pap every three) from 25 through 65 — already running when the 40s begin, and the clearest win on the map.
• 🩺 Colorectal screening at 45. The start age moved down from 50 in 2021 because colorectal cancer is rising in younger adults. The cancer-screening page covers the modality choice.
• 📏 Weight, waist, and function. Body weight, waist circumference, and a quick strength-and-mobility check cost nothing and feed the home tracking system in the Quarterly Audit protocol.

The 50s — The Add-On Decade

The 50s extend the map in two directions at once: the cancer screens reach their full span, and the menopausal transition quietly rewrites the cardiovascular risk profile that the baseline-decade labs were built on.

• 🚬 Lung CT, for the smoking history group. From 50 through 80, a 20-pack-year history earns an annual low-dose CT — the National Lung Screening Trial showed about a 20% reduction in lung cancer mortality for exactly this group. For everyone else the false positives outweigh the benefit.
• 🩸 Lipids rechecked through the transition. Estrogen's exit changes LDL in ways the 40s baseline can't predict; the bone-and-heart page explains why the transition is the moment to re-time the lipid and bone conversations together.
• 🦠 Shingles vaccine at 50. Two doses of the recombinant vaccine roughly halve shingles risk — one of the few entries on the map with essentially no downside, per the CDC schedule.
• 🎀 Mammography, without a break. The gap in coverage matters: biennial rounds through the 50s and 60s are where the trial data show the largest mortality reductions.
• 🍬 Diabetes screening every three years. For women who are overweight or obese, the USPSTF recommends a glucose check every three years starting at 35 — in the 50s this becomes the decade where the prediabetes slope often first shows itself.

The 60s — Bones Enter the Map

The defining addition of the 60s is bone density. Osteoporosis causes roughly half of women over 50 to fracture at least once, and the fracture risk curve — unlike most cancers — keeps rising steeply into the 80s and 90s. The USPSTF's 2025 statement recommends a first DEXA at 65 for average-risk women, and earlier for women with risk factors: early menopause, low body weight, smoking, heavy alcohol use, steroid use, or a fracture history. The Bone Health topic owns the biology; the screening logic here is simply that bone loss is silent until the fracture, and a DEXA is the one test that can hear it. Meanwhile the cancer screens continue through their highest-value window — breast incidence peaks in the early 70s, and colorectal screening runs through 75 — while hearing, vision, and fall-risk checks quietly join the annual visit.

The 70s and Beyond — The Subtraction Decade

The part of the map most people never see is where it stops. Around the mid-70s, the arithmetic inverts: competing causes of death accumulate, treatment becomes harder to tolerate, and overdiagnosis — finding a cancer that would never have caused harm — becomes more likely. The evidence-based stopping rules: cervical screening ends at 65 with an adequate prior record; routine mammography is recommended through 74, with the USPSTF judging the evidence insufficient beyond that; colorectal screening ends at 75, with individual decisions allowed through 85. None of this is rationing — it is the same benefit-versus-harm math that set every start age, applied honestly. What replaces the subtracted tests is a different kind of screening: falls, function, cognition, and medication burden, which for a woman in her 80s predict disability and death far more reliably than most cancer screens. The annual-appointment page shows how those conversations fit into one visit.

Questions, Answered Briefly

• 🗓️ I'm 43 and haven't started anything — am I behind? No. You are inside the baseline decade, exactly where the map expects you. Start with blood pressure, lipids, glucose, and the mammography conversation — that is the entire list, and it is short.
• 🩺 Why does mammography stop at 74 if breast cancer keeps rising? Because the risk keeps rising but the benefit of finding a slow-growing cancer shrinks — at some point the overdiagnosis column overtakes the lives saved. The boundary is honest uncertainty, which is why it is a conversation after 74, not a wall.
• 🦴 Why is the DEXA at 65 and not 50? Fracture risk climbs steeply only after the mid-60s for average-risk women, so that is where screening catches enough treatable bone loss to justify the test. Risk factors — early menopause, fractures, steroid use — pull the date earlier.
• 🧪 Do I really need the lifestyle checks if I feel fine? The diseases that kill most women — cardiovascular and metabolic — are silent by design. The blood pressure and lipid rows are the highest-value entries on the entire map, precisely because they find things that do not announce themselves.
• 📅 Where does the annual visit fit in all this? The map is what belongs on the calendar; the visit is where it happens. The final page in this series turns the whole map into one efficient yearly hour.

Related Topics